---
audienceLevel: patient
cancerTypes:
- breast
citation: NCI, 2025
language: en
lastReviewed: '2025-12-30'
license: public_domain
reviewFrequency: quarterly
source: NCI
sourceType: 02_nci_core
status: active
tags:
- treatment
title: Capivasertib - NCI
url: https://www.cancer.gov/about-cancer/treatment/drugs/capivasertib
version: v1
---

# Capivasertib - NCI

# Capivasertib

Placeholder slot

(ka-PEE-vah-SER-tib)

This page contains brief information about capivasertib
and a collection of links to more information about the use of
this drug, research results, and ongoing clinical trials.

US Brand Name(s)

Truqap

FDA Approved

Yes

[FDA label information for this drug is available at DailyMed.](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d698c106-2322-401e-b738-cbd83c843ecf&audience=consumer)

## Use in Cancer

Capivasertib
is approved to be used with [fulvestrant](/Common/PopUps/popDefinition.aspx?id=306498&version=Patient&language=English) to treat:

- **[Breast cancer](/Common/PopUps/popDefinition.aspx?id=444971&version=Patient&language=English)** that is [hormone receptor positive](/Common/PopUps/popDefinition.aspx?id=788029&version=Patient&language=English) and [HER2 negative](/Common/PopUps/popDefinition.aspx?id=774531&version=Patient&language=English) and has an abnormal *[PIK3CA](/Common/PopUps/popDefinition.aspx?id=798600&version=Patient&language=English)*, *AKT1*, or *[PTEN](/Common/PopUps/popDefinition.aspx?id=803426&version=Patient&language=English)* gene. It is used to treat adults whose breast cancer has spread and has gotten worse during or after treatment with [hormone therapy](/Common/PopUps/popDefinition.aspx?id=45110&version=Patient&language=English) or whose cancer has come back during or within 12 months of completing adjuvant therapy.

Capivasertib
is also being studied in the treatment of other types of
cancer.

## More About Capivasertib

[Definition from the NCI Drug Dictionary](https://www.cancer.gov/publications/dictionaries/cancer-drug/def/688304) - Detailed scientific definition and other names for this drug.

MedlinePlus Information on [Capivasertib](https://medlineplus.gov/druginfo/meds/a623056.html) - A lay language summary of important information about this drug that may include the following:

- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

## Research Results and Related Resources

[Targeted Therapy to Treat Cancer](https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies)

## Clinical Trials Accepting Patients

[Find Clinical Trials for Capivasertib](https://www.cancer.gov/research/participate/clinical-trials/intervention/C102564) - Check for trials from NCI's list of cancer clinical trials now accepting patients.
